Written questions by Forster.

Whether he has reviewed the adequacy of support that General Practitioners receive when helping people access ADHD Medication.

The National Institute for Health and Care Excellence’s (NICE) attention deficit hyperactivity disorder (ADHD) guideline does not set out a timeframe within which medication should be provided, but it does explain the key considerations for clinicians when deciding whether to offer medication.It is the responsibility of integrated care boards in England to make available appropriate provision to meet the health and care needs of their local population, including providing access to ADHD support services including medication, in line with relevant NICE guidelines.The General Medical Council (GMC) has issued guidance on prescribing and managing medicines, which helps general practices (GPs) decide whether to accept shared care responsibilities. In deciding whether to enter into a shared care agreement, a GP will need to consider a number of factors such as whether the proposed activity is within their sphere of competence, and therefore safe and suitable for their patient’s needs. This includes the GP being satisfied that any prescriptions or referrals for treatment are clinically appropriate.All United Kingdom registered doctors are expected to meet the professional standards set out in the GMC’s Good Medical Practice. In 2012, the GMC introduced revalidation which supports doctors in regularly reflecting on how they can develop or improve their practice, gives patients confidence doctors are up to date with their practice, and promotes improved quality of care by driving improvements in clinical governance. If a shared care arrangement cannot be put in place after the treatment has been initiated, the responsibility for continued prescribing falls upon the specialist clinician, and this applies to both NHS and private medical care.My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities. The final report, due in the summer, will make recommendations on how the Government, the health system, and wider public services can respond to increasing demand for support more fairly and effectively so that people receive the right support, at the right time, in the right place.

Whether his Department has reviewed the success of shared care agreements with private providers when it comes to ADHD patient cases.

Shared care within the National Health Service refers to a voluntary arrangement whereby a specialist may transfer responsibility for aspects of a patient’s care, such as prescription of medication, to the patient’s general practitioner (GP). Decisions regarding shared care agreements are made locally, and the General Medical Council has made it clear that GPs are not contractually obliged to enter shared care agreements and may decline requests on clinical or capacity grounds.No specific review has been made of the success of shared care agreements with private providers for patients with attention deficit hyperactivity disorder.

What plans his department has to tackle the decline in the number of health visits to families with young children.

The number of health visits which must be offered to families in England has remained the same since 2015, with additional support provided according to need. Families must be offered at least five health visits, with four of these taking place post birth.Health visiting service delivery data for England is published annually. The latest published data shows that, at a national level, a greater percentage of children received each post-birth health visit in 2024/25 compared to 2023/24, with the datasets and statistical commentaries available at the following two links:https://www.gov.uk/government/statistics/health-visitor-service-delivery-metrics-april-2023-to-march-2024-annual-2023-to-2024https://www.gov.uk/government/statistics/health-visitor-service-delivery-data-for-2024-to-2025However, we recognise there is unwarranted regional variation in delivery, and we are working to reduce this. In line with the Government’s commitment to strengthening health visiting, set out in the Best Start in Life Strategy, we have recently published refreshed guidance for the Healthy Child Programme, which specifies requirements for health visiting services, in order to strengthen delivery and promote consistency in service quality. We are working closely with regional colleagues to support the implementation of this guidance across the country.

What guidance his Department has provided to Iranians visiting the UK, who have with health conditions, that are unable to return to Iran.

The Department has not issued any specific guidance for Iranians with health conditions who are visiting the United Kingdom. Furthermore, the Department of Health and Social Care has not engaged in discussions with the Foreign, Commonwealth and Development Office concerning Iranians visiting the UK who require cancer treatment.In England, the National Health Service is a residency‑based system and only those who are ordinarily resident in the UK, or otherwise exempt under the NHS (Charges to Overseas Visitors) Regulations 2015, are entitled to NHS care without charge, however, decisions about whether treatment is provided are always made by clinicians on the basis of clinical need, and urgent or immediately necessary care must not be delayed or denied because of charging considerations.

What conversations his Department has had with the Foreign, Commonwealth and Development Office regarding cancer patients visiting the UK on a visa who are undergoing treatment in Iran; and whether it has a plan to deal with the impact of the war on people with cancer in this predicament.

The Department has not issued any specific guidance for Iranians with health conditions who are visiting the United Kingdom. Furthermore, the Department of Health and Social Care has not engaged in discussions with the Foreign, Commonwealth and Development Office concerning Iranians visiting the UK who require cancer treatment.In England, the National Health Service is a residency‑based system and only those who are ordinarily resident in the UK, or otherwise exempt under the NHS (Charges to Overseas Visitors) Regulations 2015, are entitled to NHS care without charge, however, decisions about whether treatment is provided are always made by clinicians on the basis of clinical need, and urgent or immediately necessary care must not be delayed or denied because of charging considerations.

How many times the NHS has settled employment disputes and whistleblowing complaints before going to court in the last five years.

The Department does not hold the information requested. Each National Health Service employer should hold this information for their own organisation. NHS organisations as independent employers who manage their own employment disputes and whether and how to settle claims prior to an Employment Tribunal or court hearing.

Whether his Department plans to assess eligibility for the Immigration Health Surcharge reimbursement scheme for roles supporting NHS services not directly employed by NHS organisations.

When applying for an Immigration Health Surcharge (IHS) reimbursement, the applicant must satisfy the requirement of ‘eligible work’ as set out in the IHS guidance. Applicants need to be working in a role where they provide a service which is related to the delivery of health or social care and are either employed or engaged to do the work by a recognised health or care provider, for example, National Health Service trusts or national NHS bodies.There are currently no plans to assess eligibility for the IHS reimbursement scheme for roles supporting NHS services not directly employed by NHS organisations.

How much the NHS has spent on legal costs and compensation following employment disputes and whistleblowing complaints in the last five years.

Information is not held centrally as it is held at trust level. The Department and NHS England do not hold employment dispute data for all National Health Service employers. Employment disputes are typically raised against an individual employee’s employing organisation, and each trust are separate employers.

Whether his Department plans to review its approach to employment disputes and whistleblowing complaints.

National Health Service organisations are independent employers and have their own policies and procedures for resolving workplace disputes, including whistleblowing complaints, which should be aligned to current employment law and relevant Advisory, Conciliation and Arbitration Service codes of practice or guidance.The Department for Business and Trade and the Ministry of Justice have set up the Dispute Resolution System Taskforce to consider longer-term system reform of dispute resolution across all sectors.

What assessment he has made of the potential impact of commissioning controls, including Indicative Activity Plans, on access to children’s ADHD and autism assessments.

Patients have a legal Right to Choose their provider when referred for National Health Service funded eligible care.In 2023, NHS England published National framework and operational guidance for autism assessment services aimed at supporting those in commissioning roles during their commissioning cycles and operational guidance to support and inform decision-making at service level. These two guidance documents are available, respectively, at the following two links:https://www.england.nhs.uk/publication/autism-diagnosis-and-operational-guidance/https://www.england.nhs.uk/long-read/operational-guidance-to-deliver-improved-outcomes-in-all-age-autism-assessment-pathways-guidance-for-integrated-care-boards/Integrated care boards are responsible for ensuring that their processes comply with the legal Right to Choose.NHS England is aware that commissioning controls on levels of assessment activity have been set by some commissioners and is working with systems to develop a supporting document to the NHS Payment Scheme 2026/27 statutory consultation to help identify the costs associated with undertaking autism and attention deficit hyperactivity disorder (ADHD) assessments. This aims to help guide the pricing and create a more equitable and consistent approach to the autism and ADHD assessment payment process. NHS England published the NHS Standard Contract which requires integrated care boards (ICBs) to agree indicative activity plans (IAPs) for any service area which is variably funded, to aid in planning and capacity and demand management. IAPs are planning tools which do not restrict activity carried out by a provider.The NHS Medium Term Planning Framework requires ICBs to undertake thorough demand and capacity planning and to strategically commission services that meet the needs of their patient population. ICBs may need to prioritise certain areas of care for their patient population, which may include managing planned assessment activity in some areas through Activity Management Plans.My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our new approach to mental health, so people receive the right support, at the right time and in the right place. Likewise, the review will inform our approach so that people with ADHD and autistic people have the right support in place to enable them to live well in their communities.

Whether future NHS planning guidance will require Integrated Care Boards to provide dedicated long covid pathways.

Integrated care boards (ICBs) are allocated funding by the National Health Service based on a statistical formula which takes into account population size and needs, so that funding distribution is fair and objective. Further details on ICB funding allocation can be found at the following link:https://www.england.nhs.uk/allocations/The allocation of funding for specialised services, including long COVID, are at the discretion of local ICBs to best meet the needs of their local population.Commissioning guidance, from December 2023, presents guidelines for the commissioning and oversight of post-COVID services by ICBs in England for adults, and children and young people from April 2024. Since then, in line with the NHS operating framework and the establishment of integrated care systems, the commissioning of post-COVID services has been the responsibility of ICBs. However, according to this guidance, post-COVID services should comprise an integrated pathway of assessment, medical treatment, and multifaceted rehabilitation, including psychology, with direct access to required diagnostics. Referral should be via a single point of access which is managed by clinician-led triage.

How much funding was allocated to each Integrated Care Board in England for long covid services in the 2024-25 financial year.

Integrated care boards (ICBs) are allocated funding by the National Health Service based on a statistical formula which takes into account population size and needs, so that funding distribution is fair and objective. Further details on ICB funding allocation can be found at the following link:https://www.england.nhs.uk/allocations/The allocation of funding for specialised services, including long COVID, are at the discretion of local ICBs to best meet the needs of their local population.Commissioning guidance, from December 2023, presents guidelines for the commissioning and oversight of post-COVID services by ICBs in England for adults, and children and young people from April 2024. Since then, in line with the NHS operating framework and the establishment of integrated care systems, the commissioning of post-COVID services has been the responsibility of ICBs. However, according to this guidance, post-COVID services should comprise an integrated pathway of assessment, medical treatment, and multifaceted rehabilitation, including psychology, with direct access to required diagnostics. Referral should be via a single point of access which is managed by clinician-led triage.

What steps he is taking to help ensure that patients with long covid receive condition specific care.

Long COVID, or post-COVID, services are commissioned by integrated care boards. These services should comprise of an integrated pathway of assessment, medical treatment, and multifaceted rehabilitation, with direct access to required diagnostics. Referral should be via a single point of access which is managed by clinician-led triage. At all stages in the care pathway, patients should be offered a range of support, treatment, and rehabilitation services, depending on the specific needs of the individual.NHS England has set up specialist post-COVID services nationwide for adults, and children and young people, and is investing in ensuring general practice teams are equipped to support people affected by the condition. The Living with Covid Recovery mobile phone app also supports people recovering from long COVID at home. The app has enabled the National Health Service to monitor and support the recovery of those suffering from long COVID more effectively.While there is no single treatment for long COVID, there are treatments available to help manage some of the symptoms. Specifically, the Government has funded clinical trials to test and compare different treatments such as antihistamines, anticoagulants, and anti-inflammatory medicines, as well as trials such as REGAIN.The Neighbourhood Health Service, delivered by new multidisciplinary teams of professionals, will embody our new preventative principle that care should happen as locally as it can, to support more services being delivered in the community, including for people with long COVID.

What assessment he has made of the potential impact of business rate increases on the community pharmacy network.

In the Autumn Budget 2025, the Government took the hard choices to protect the National Health Service in England and continue to prioritise reducing waiting times. We have also stepped in to cap bills and help businesses, as part of a £4.3 billion support package.This year, we have also increased funding to community pharmacies to almost £3.1 billion, the largest uplift in funding for any part of the NHS across 2024/25 and 2025/26.The Department will consult Community Pharmacy England on any proposed changes to reimbursement and remuneration of pharmacy contractors for 2026/27 shortly.

If he will (a) review and (b) reform the current community pharmacy contract.

In the Autumn Budget 2025, the Government took the hard choices to protect the National Health Service in England and continue to prioritise reducing waiting times. We have also stepped in to cap bills and help businesses, as part of a £4.3 billion support package.This year, we have also increased funding to community pharmacies to almost £3.1 billion, the largest uplift in funding for any part of the NHS across 2024/25 and 2025/26.The Department will consult Community Pharmacy England on any proposed changes to reimbursement and remuneration of pharmacy contractors for 2026/27 shortly.

What steps the Government is taking to help raise awareness of 22q11.2 deletion syndrome.

The Government is committed to improving the lives of people living with rare diseases through the UK Rare Diseases Framework. One of the priorities of the Framework is improving awareness of rare diseases among healthcare professionals, including 22q11.2 deletion syndrome, also known as DiGeorge syndrome. In England, we will publish the fifth action plan updating on the progress of this priority of the UK Rare Diseases Framework in spring 2026.NHS England supports increased awareness and understanding of DiGeorge syndrome through the NHS Genomics Education Programme which provides accessible evidence-based resources aimed at healthcare professionals, including a dedicated page on 22q deletion syndrome to support recognition, referral and appropriate use of genomic testing. Such resources are available at the following link: https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/22q11-2-deletion-syndrome/ Information for families is also available at the following link: https://www.nhs.uk/conditions/digeorge-syndrome/

What information his Department hols on the longest time that someone has had to wait to obtain a wheelchair or walker on the NHS.

The information requested is not held centrally. Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population.NHS England supports ICBs to reduce variation in the quality and provision of National Health Service wheelchairs, and to reduce delays in people receiving timely intervention and wheelchair equipment. Since July 2015, NHS England has collected quarterly data from clinical commissioning groups, now ICBs, on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information is avaiable at the following link:https://digital.nhs.uk/data-and-information/publications/statistical/nhse-national-wheelchair-data-collection/q2-2025-26The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adults through the Wheelchair, Orthotics, Prosthetics and Equipment line, with further information avaiable at the following link: https://www.england.nhs.uk/statistics/statistical-work-areas/community-health-services-waiting-lists/The NHS Medium-Term Planning Framework, published October 2025, requires that, from 2026/27, all ICBs and community health services must actively manage and reduce the proportion of waits across all community health services over 18 weeks and develop a plan to eliminate all 52-week waits.These targets will guide systems to reduce longest waits. Improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.

What steps his Department is taking to help ensure children receive appropriate NHS funded physical health and mental health support while they are waiting for an EHCP.

Health services for children and young people are based on clinical need. Children and young people with special educational needs and disabilities (SEND) can access National Health Services, including community services, in the usual way, within the local offer, regardless of whether they have an Education, Health and Care Plan (EHCP) or are awaiting an EHCP. Any health need over and above the local offer should be accessed via an individual funding request to the integrated care board.Regardless of whether or not a child or young person has an EHCP, a school or other institution has a legal duty under the Children and Families Act 2014 to support children with health conditions, which is outlined in statutory guidance, which is available at the following link:https://www.gov.uk/government/publications/supporting-pupils-at-school-with-medical-conditions--3Work is currently underway to stabilise and improve NHS mental health services, but there is much more to do. Through the 10-Year Health Plan we will accelerate the rollout of Mental Health Support Teams in schools and colleges to reach full national coverage by 2029. We will boost the capability and capacity of staff so that they can offer more effective support to young people with complex needs, such as trauma, neurodivergence, and disordered eating. As part of this, we will invest £13 million to pilot enhanced training for staff, which will inform future phases of the programme.

What the average waiting time is for someone to obtain a wheelchair or walker on the NHS.

The information requested is not held centrally. Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population.NHS England supports ICBs to reduce variation in the quality and provision of National Health Service wheelchairs, and to reduce delays in people receiving timely intervention and wheelchair equipment. Since July 2015, NHS England has collected quarterly data from clinical commissioning groups, now ICBs, on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information is available at the following link:https://digital.nhs.uk/data-and-information/publications/statistical/nhse-national-wheelchair-data-collection/q2-2025-26The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adults through the Wheelchair, Orthotics, Prosthetics and Equipment line, with further information available at the following link: https://www.england.nhs.uk/statistics/statistical-work-areas/community-health-services-waiting-lists/The NHS Medium-Term Planning Framework, published October 2025, requires that, from 2026/27, all ICBs and community health services must actively manage and reduce the proportion of waits across all community health services over 18 weeks and develop a plan to eliminate all 52-week waits.These targets will guide systems to reduce longest waits. Improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.

Whether his Department has made an assessment of the potential impact of the abolition of NHS England on pension schemes for NHS England workers.

The abolition of NHS England is not expected to have a significant impact on the overall financing of the NHS Pension Scheme for England and Wales. The NHS Pension scheme is one the largest pension schemes in the United Kingdom, with approximately 1.8 million active members. An actuarial valuation is conducted every four years to ensure the level of contributions made by members and employers meet the full cost of their pension rights as they accrue them. Those accrued pension rights are underwritten by the Exchequer and will be paid in full when a member retires.